Continence Care Market Introduction and Overview
According to SPER Market Research, the Global Continence Care Market is estimated to reach USD 4.09 billion by 2034 with a CAGR of 5.09%.
The growth of the continence care products market is driven by several factors, including the rising prevalence of urinary incontinence, an aging population, advancements in technology, and an increasing demand for minimally invasive procedures. The elderly are particularly prone to bladder-related issues such as chronic kidney disease (CKD), urinary retention, leakage, and urinary incontinence (UI). The growing geriatric population is a key factor fueling the market's expansion. The World Health Organization (WHO) projects that the global population aged 60 and over will reach 1.5 billion by 2030, highlighting the rising incidence of bladder and bowel control problems. This demographic shift is increasing demand for healthcare solutions tailored to the needs of older adults. As a result, the pharmaceutical and healthcare sectors are experiencing significant growth, with a focus on products designed to address the unique needs of the aging population, further contributing to the market’s robust expansion. However, the high costs of continence care products pose a significant barrier to market expansion, as people with lower incomes or limited healthcare coverage may be unable to buy them. This expensive burden limits access to vital continence care treatments, especially for those in greatest need. Furthermore, the social stigma associated with urinary disorders slows market growth by discouraging people from seeking necessary treatments or care.
By Product Type: The market is segmented by product type into urinary catheters, urinary bags and pouches, absorbent products, and others. In 2022, the absorbent products segment held the largest share of the continence care products market in terms of revenue and is expected to maintain its dominance throughout the forecast period. This is primarily due to the growing aging population, who are more prone to urinary incontinence, driving the demand for absorbent products. These products offer convenience and comfort to individuals dealing with urinary issues.
On the other hand, the urinary catheters segment is anticipated to experience the fastest compound annual growth rate (CAGR) during the forecast period. This growth is attributed to several factors, including an increase in urinary tract infections and urinary retention disorders, technological innovations leading to more advanced and user-friendly catheters, and greater awareness among healthcare professionals and patients about the advantages of catheterization in managing urinary problems.
By Gender: Based on gender, The continence care products market is segmented by gender, with females currently representing the larger market share. This is due to the higher incidence of urinary incontinence and related conditions among women. The female segment is also expected to experience the fastest growth, driven by increased awareness and acceptance of women's urinary health issues, along with advancements in product design specifically tailored to female anatomy and needs.
By category: Based on Category, the market is categorized into disposable and reusable segments. In 2022, the disposable segment held the largest share of the continence care products market in terms of revenue and is projected to grow at the fastest compound annual growth rate (CAGR) during the forecast period. This growth is mainly driven by the convenience, hygiene, and cost-effectiveness offered by disposable products. Rising awareness of infection prevention, along with the ease of use and disposal, has increased the preference for disposable items, further reinforcing their dominance in the market.
By End Use: By end use, The market is segmented into hospitals and clinics, home care, and other end-user categories. In terms of revenue, the hospitals and clinics segment dominated the continence care products market in 2022 and is likely to hold that position throughout the forecast period. This is largely owing to the extensive use of urinary products in medical settings, notably during treatment and after surgery. These facilities rely on these medications to treat a variety of urinary disorders, improve patient comfort, and prevent infection. This segment's widespread use in medical treatments and postoperative care emphasizes its relevance.
By Region: Geographically, the market for continence care products is examined in North America, Europe, Asia-Pacific, and Latin America. In 2022, North America held the greatest revenue share, and its advanced medical facilities and established healthcare infrastructure are likely to keep it that way during the projection period. The strong economy of the area makes large investments in healthcare technology, research, and development possible. The market is also growing because of the rising adoption of continence care products and the high awareness of the availability of continence management solutions.
Market Competitive Landscape:
The Global Continence Care Market is highly consolidated. Some of the market players are
ABENA, Attends Healthcare Products, Inc., BD (Becton, Dickinson and Company), Boston Scientific Corporation, Cardinal Health, Coloplast Group, ConvaTec Group Plc, Essity Aktiebolag, First Quality Enterprises, Inc., Hollister Incorporated, KCWW (Kimberly-Clark Corporation), Medline Industries, Inc., Ontex Healthcare, Paul Hartmann AG, Salts Healthcare Ltd., Teleflex Incorporated, Wellspect HealthCare, Others.
Recent Developments:
- Convatec announced in August 2024 that its free digital app would be available in the United States to help new intermittent catheter users and their medical providers.
- Coloplast introduced the Luja Female intermittent catheter in May 2024. Its purpose is to lower the incidence of urinary tract infections (UTIs) by allowing the bladder to empty completely in a single flow. It is environmentally friendly, using 28% less plastic and leaving a smaller carbon footprint thanks to Micro-hole Zone Technology.
- Clinisupplies expanded its continence care solutions in October 2023 when it purchased the Aquaflush transanal irrigation (TAI) portfolio from Renew Medical. The purpose of this acquisition is to increase Clinisupplies' product line and assist patients with chronic bowel disorders.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product Type, By Gender, By Category, By End Use. |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe. |
| Companies Covered | ABENA, Attends Healthcare Products, Inc., BD (Becton, Dickinson and Company), Boston Scientific Corporation, Cardinal Health, Coloplast Group, ConvaTec Group Plc, Essity Aktiebolag, First Quality Enterprises, Inc., Hollister Incorporated, KCWW (Kimberly-Clark Corporation), Medline Industries, Inc., Ontex Healthcare, Paul Hartmann AG, Salts Healthcare Ltd., Teleflex Incorporated, Wellspect HealthCare, Others. |
Key Topics Covered in the Report:
- Global Continence Care Market Size (FY’2021-FY’2034)
- Overview of Global Continence Care Market
- Segmentation of Global Continence Care Market By Product Type (Urinary catheters, Urinary bags and pouch, Absorbent Products, Others)
- Segmentation of Global Continence Care Market By Gender (Male, Female)
- Segmentation of Global Continence Care Market By Category (Disposable, Reusable)
- Segmentation of Global Continence Care Market By End Use (Hospitals and clinics, Home care, Others)
- Statistical Snap of Global Continence Care Market
- Expansion Analysis of Global Continence Care Market
- Problems and Obstacles in Global Continence Care Market
- Competitive Landscape in the Global Continence Care Market
- Details on Current Investment in Global Continence Care Market
- Competitive Analysis of Global Continence Care Market
- Prominent Players in the Global Continence Care Market
- SWOT Analysis of Global Continence Care Market
- Global Continence Care Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Continence Care Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Continence Care Market
7. Global Continence Care Market, By Product Type (USD Million) 2021-2034
7.1. Urinary catheters
7.2. Urinary bags and pouch
7.3. Absorbent Products
7.4. Others
8. Global Continence Care Market, By Gender (USD Million) 2021-2034
8.1. Male
8.2. Female
9. Global Continence Care Market, By Category (USD Million) 2021-2034
9.1. Disposable
9.2. Reusable
10. Global Continence Care Market, By End User (USD Million) 2021-2034
10.1. Hospitals and clinics
10.2. Home care
10.3. Others
11. Global Continence Care Market 2021-2034 (USD Million)
11.1. Global Continence Care Market Size and Market Share
12. Global Continence Care Market, By Region, (USD Million) 2021-2034
12.1. Asia-Pacific
12.1.1. Australia
12.1.2. China
12.1.3. India
12.1.4. Japan
12.1.5. South Korea
12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France
12.2.2. Germany
12.2.3. Italy
12.2.4. Spain
12.2.5. United Kingdom
12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia
12.3.2. United Arab Emirates
12.3.3. Qatar
12.3.4. South Africa
12.3.5. Egypt
12.3.6. Morocco
12.3.7. Nigeria
12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada
12.4.2. Mexico
12.4.3. United States
12.5. Latin America
12.5.1. Argentina
12.5.2. Brazil
12.5.3. Rest of Latin America
13. Company Profile
13.1. ABENA
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. Attends Healthcare Products, Inc.
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. BD (Becton, Dickinson and Company)
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. Boston Scientific Corporation
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. Cardinal Health
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. Coloplast Group
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. ConvaTec Group Plc
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Essity Aktiebolag
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. First Quality Enterprises, Inc.
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. Hollister Incorporated
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. KCWW (Kimberly-Clark Corporation)
13.11.1. Company details
13.11.2. Financial outlook
13.11.3. Product summary
13.11.4. Recent developments
13.12. Medline Industries, Inc.
13.12.1. Company details
13.12.2. Financial outlook
13.12.3. Product summary
13.12.4. Recent developments
13.13. Ontex Healthcare
13.13.1. Company details
13.13.2. Financial outlook
13.13.3. Product summary
13.13.4. Recent developments
13.14. Paul Hartmann AG
13.14.1. Company details
13.14.2. Financial outlook
13.14.3. Product summary
13.14.4. Recent developments
13.15. Salts Healthcare Ltd.
13.15.1. Company details
13.15.2. Financial outlook
13.15.3. Product summary
13.15.4. Recent developments
13.16. Teleflex Incorporated
13.16.1. Company details
13.16.2. Financial outlook
13.16.3. Product summary
13.16.4. Recent developments
13.17. Wellspect HealthCare
13.17.1. Company details
13.17.2. Financial outlook
13.17.3. Product summary
13.17.4. Recent developments
13.18. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links